Small molecule suppression of carbapenem resistance in ndm-1 producing klebsiella pneumoniae

ACS Medicinal Chemistry Letters

Volumn 3, Issue 5, 2012, Pages 357-361

  Worthington, Roberta J ^a   Bunders, Cynthia A ^a   Reed, Catherine S ^a   Melander, Christian ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAPENEM; IMIPENEM; MEROPENEM; METALLO BETA LACTAMASE; PROTEIN NDM1; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERICIDAL ACTIVITY; BACTERIUM ISOLATION; COLONY FORMING UNIT; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

KLEBSIELLA PNEUMONIAE; NEGIBACTERIA;

EID: 84861056112     PISSN: None     EISSN: 19485875     Source Type: Journal    
DOI: 10.1021/ml200290p     Document Type: Article

References (18)

1. Payne, D. J. Microbiology. Desperately seeking new antibiotics Science 2008, 321, 1644-1645
2. Spellberg, B.; Guidos, R.; Gilbert, D.; Bradley, J.; Boucher, H. W.; Scheld, W. M.; Bartlett, J. G.; Edwards, J., Jr. The epidemic of antibiotic-resistant infections: A call to action for the medical community from the Infectious Diseases Society of America Clin. Infect. Dis. 2008, 46, 155-164 (Pubitemid 351269151)
3. Giamarellou, H. Multidrug-resistant Gram-negative bacteria: How to treat and for how long Int. J. Antimicrob. Agents 2010, 36S, S50-S54
4. Ko, W.; Paterson, D. L.; Sagnimeni, A. J.; Hansen, D. S.; Von Gottberg, A.; Mohapatra, S.; Casellas, J.; Goossens, H.; Mulazimoglu, L.; Trenholme, G.; Klugman, K. P.; McCormack, J. G.; Yu, V. L. Community-acquired Klebsiella pneumoniae bacteremia: Global differences in clinical patterns Emerging Infect. Dis. 2002, 8, 160-166 (Pubitemid 34202438)
5. Kaczmarek, F. M.; Dib-Hajj, F.; Shang, W.; Gootz, T. D. High-level carbapenem resistance in a Klebsiella pneumoniae clinical isolate is due to the combination of bla ACT-1 ß-lactamase production, porin OmpK35/36 insertional inactivation, and down-regulation of the phosphate transport porin PhoE Antimicrob. Agents Chemother. 2006, 50, 3396-3406 (Pubitemid 44527516)
6. Emery, C. L.; Weymouth, L. A. Detection and clinical significance of extended-spectrum beta-lactamases in a tertiary-care medical center J. Clin. Microbiol. 1997, 35, 2061-2067 (Pubitemid 27318705)
7. French, G. L. The continuing crisis of antibiotic resistance Int. J. Antimicrob. Agents 2010, 36S3, S3-S7
8. Nordmann, P.; Poirel, L.; Toleman, M. A.; Walsh, T. R. Does broad-spectrum ß-lactam resistance due to NDM-1 herald the end of the antibiotic era for treatment of infections caused by Gram-negative bacteria J. Antimicrob. Chemother. 2011, 66, 689-692
9. Sidjabat, H; Nimmo, G. R.; Walsh, T. R.; Binotto, E.; Htin, A.; Hayashi, Y.; Li, J.; Nation, R. L.; George, N.; Paterson, D. L. Carbapenem resistance in Klebsiella pneumoniae due to the New Delhi metallo-β-lactamase Clin. Infect. Dis. 2011, 52, 481-484
10. Conly, J.; Johnston, B. Where are all the new antibiotics? The new antibiotic paradox Can. J. Infect. Dis. Med. Microbiol. 2005, 16, 159-160 (Pubitemid 41113429)
11. Dolgin, E. Sequencing of superbugs seen as key to combating their spread Nature Med. 2010, 16, 1054-1054
12. Kalan, L.; Wright, G. D. Antibiotic adjuvants: Multicomponent anti-infective strategies Expert Rev. Mol. Med. 2011, 13, 1-17
13. Rogers, S. A.; Huigens, R. W.; Cavanagh, J.; Melander, C. Synergistic effects between conventional antibiotics and 2-aminoimidazole-derived antibiofilm agents Antimicrob. Agents Chemother. 2010, 54, 2112-2118
14. CSLI. Performance Standards for Antimicrobial Susceptibility Testing; Twentieth Informational Supplement; Clinical and Laboratory Standards Institute: Wayne, PA, January, 2010; M100-S20, Vol. 30, No. 1.
15. Huigens, R. W.; Reyes, S.; Reed, C. S.; Bunders, C.; Rogers, S. A.; Steinhauer, A. T.; Melander, C. The chemical synthesis and antibiotic activity of a diverse library of 2-aminobenzimidazole small molecules against MRSA and multidrug-resistant A. baumannii Bioorg. Med. Chem. 2010, 18, 663-674
16. CSLI. Performance Standards for Antimicrobial Susceptibility Testing; Twentieth Informational Supplement (June 2010 update); Clinical and Laboratory Standards Institute: Wayne, PA, January, 2010; M100-S20, Vol. 30, No. 15.
17. Su, Z.; Peng, L.; Worthington, R. J.; Melander, C. Evaluation of 4,5-disubstituted-2-aminoimidazoles for dual antibiofilm/antibiotic resensitization activity ChemMedChem 2011, 6, 2243-2251
18. Hilliard, J. J.; Goldschmidt, R. M.; Licata, L.; Baum, E. Z.; Bush, K. Multiple mechanisms of action for inhibitors of histidine protein kinases frombacterial two-component systems Antimicrob. Agents Chemother. 1999, 43, 1693-1699 (Pubitemid 29331249)